SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012533
Filing Date
2022-08-08
Accepted
2022-08-08 09:00:43
Documents
89
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ganx-20220630x10q.htm   iXBRL 10-Q 2040603
2 EX-31.1 ganx-20220630xex31d1.htm EX-31.1 10932
3 EX-31.2 ganx-20220630xex31d2.htm EX-31.2 10399
4 EX-32.1 ganx-20220630xex32d1.htm EX-32.1 10300
  Complete submission text file 0001558370-22-012533.txt   8023301

Data Files

Seq Description Document Type Size
5 EX-101.SCH ganx-20220630.xsd EX-101.SCH 60085
6 EX-101.CAL ganx-20220630_cal.xml EX-101.CAL 61459
7 EX-101.DEF ganx-20220630_def.xml EX-101.DEF 205341
8 EX-101.LAB ganx-20220630_lab.xml EX-101.LAB 521222
9 EX-101.PRE ganx-20220630_pre.xml EX-101.PRE 392095
83 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20220630x10q_htm.xml XML 1241877
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40237 | Film No.: 221142742
SIC: 2834 Pharmaceutical Preparations